Atopic dermatitis is a chronic disease that disproportionately impacts communities of color Dupixent achieved 75% or greater improvement in overall disease severity, the primary endpoint, in more than three-quarters of treated patients Patients…Read More
You might also be interested in reading BullPerks Successfully Ended Private Funding Round Raising $1.8M.